CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Duchembio Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Duchembio Co Ltd
6/7F
Seobong Gallery, 81, Wausan-ro, Mapo-gu
Phone: +82 23324868p:+82 23324868 SEOUL, 04041  South Korea Ticker: 176750176750

Business Summary
DuChemBio Co Ltd is a Korea-based company primarily engaged in the manufacture and sale of radiopharmaceuticals. The Company primarily develops, manufactures, and sells radiopharmaceuticals for the diagnosis and treatment of cancer and brain diseases. The Company's main products include radiopharmaceuticals for the diagnosis of malignant tumors, heart disease, and epilepsy. The Company also manufactures, sells, and leases related equipment, including distribution systems for medical institutions.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202412/31/2024Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer, Vice President, Director Sang WuKim 51 9/1/2023 9/1/2023
Internal Auditor Han SikChae 55 6/27/2024 6/27/2024
Director Hak GyeongKim 61 6/5/2024 6/5/2024
Director Jin TaeKim 51 11/1/2021 11/1/2021
Non-Executive Independent Director Gyeong HoLee 72 3/29/2022 3/29/2022

General Information
Number of Employees: 133 (As of 12/31/2023)
Outstanding Shares: 28,344,712 (As of 12/31/2024)
Shareholders: 1,039
Stock Exchange: KDQ
Fax Number: +82 23233437


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, March 28, 2025